SureTrader SureTrader
Home > Boards > US OTC > Miscellaneous >

EP Global Communications, Inc. (EPGL)

EPGL RSS Feed
Add EPGL Price Alert      Hide Sticky   Hide Intro
Moderator: Atlanta1, flaflyersfan, integral, Stock Barber, BADALI, baryoboy
Search This Board:
Last Post: 12/10/2016 7:00:52 AM - Followers: 473 - Board type: Free - Posts Today: 1
 

                         


About the Company:

EP Global Communications, Inc. is an Advanced Technology Research and Development company for both Medical Devices and Consumer Electronics Devices specializing in Microelectronic Mechanical Systems (MEMS). For more information about the company, please click on the banner above to be directed to the comapny website.

People, Products & Process:
EPGL has assembled an impressive team to propel the company into a bright future and to build shareholder value. Under the leadership of Michael Hayes EPGL underwent debt restructuring, assembly of a new management team, as well as medical and scientific personnel. Mr. Hayes has made it a singular priority to bring aboard only the world’s top professionals in the field of medical sciences to EPGL and thereby build the Company into a major player in the Medical Device Industry over the next several years. He has also committed to prioritizing shareholders and creating significant value for their investment over time. We have seen great evidence of the har work over the last couple years as EPGL has signed Development Agreements with CooperVision, Intel, and AT&T. EPGL is in negotiations to licence technology to CooperVision presently. On April 28th 2015, EPGL disclosed to shareholders that
EPGL and AT&T have created joint Intellectual Properties and are now in the process of procuring those properties. Shareholders can expect developments on this in the near future.


One key team member that was brought on board is David Markus (Vice President, BioMEMS) Developer, As you will see David Markus is a Well Accomplished Engineer.

David T. Markus holds a Ph.D. in Biomedical Engineering and a MS in Electrical Engineering with an emphasis in MEMS Microelectronics and Biomedical. Dr. Markus spent 11 years with Raytheon and holds 8 US patents and has 9 other US Patents Pending. He has been involved in research for several of the world's leading technological institutions, including the Office of Naval Research in Arlington, Virginia, NASA Jet Propulsion Laboratory in Pasadena, CA and he has been published 15 times for various technical conferences. He was a principal investigator on SBIR DARPA Phase I and Phase II, and "Ultraflexible Substrate" for Macroelectronics Program by Dr. Robert Reuss at DARPA. He has been involved in the engineering and the development on seven surgical devices, including devices for Cataract surgery, Intra-Ocular Lens Delivery, Arthroscopy, Endodontic Endoscope, Micro Endoscope and Neural Electrodes. Additionally he was instrumental on developing three medical laboratory devices, including for In-Vitro Fertilization, PCR instrumentation and drug discovery.

The Company has significant know-how and Intellectual Property in the arena of BioMEMS and has invented new device technologies which include, but are not limited to the following:
 
1. Advanced Power Source for Contact Lenses 11. Advanced TopSpin Platform Technology for Development of Smart Medical Devices
2. Advanced Cell Regeneration Technology to Treat Eye Disease 12. Advanced Device for Steam Cell Treatment Delivery
3. Advanced Cell Regeneration Technology to Treat Hearing Loss 13. Advanced Device for Treatment of Prostate Tumors
4. Advanced Nerve Ablation Device 14. Advanced Endoscopic Device
5. Advanced Epidural Device 15. Advanced Device for Delievery of Micron Sized Drug Payloads
6. New & Promsing Treatment of Restinitis Pigmentosa 16. New & Promising Device for Treatment of Macular Degeneration
7. Advanced Ablation Device for Nerve Treatment of Facial Glabballar Frownig 17. New Advanced Contact Lens Device
8. New Advanced PowerSource for TopSpin Medical Devices 18. Advanced Device For Delivery of Micro Mechanical Devices Into Body
9. Advanced Trigger Point Needle Device 19.  Device for  Advanced Biopsy
10. Advanced Micron Resolution Motor for Smart Medical Devices 20. Real-Time Sensor Technologies for Connectivity to a Global Network  **NEW
21.Real-Time Data Applications for Athletic Teams, Workforces and Military Forces*NEW
 
EPGL develops advanced technololgies and in negotiations currently to license them to medical device companies and consumer electronic companies.

Contract with CooperVision:
EPGL and CooperVision, Inc. (CooperVision) have signed an exclusive Development Agreement for Advanced Ophthalmic and Medical Technologies. CooperVision is a market leader in the manufacturing and marketing of contact lenses. The Cooper Companies recently completed the acquisition of Sauflon Pharmaceuticals Limited for approximately $1.2 Billion Dollars.

Material Disclosure to Shareholdrs EPGL MED JOINT PATENT VALIDATION
(Includes EPGL MED, COOPERVISION, David T.Markus, Aurthur Back, Luke A.Kilyk, Michael Hayes)

https://www.otciq.com/otciq/ajax/showFinancialReportById.pdf?id=141220
 

Exclusive Development Agreement Signed with CooperVision, Inc., a Division of The Cooper Companies, Inc. (COO, NYSE)
https://www.otciq.com/otciq/ajax/showFinancialReportById.pdf?id=125904



Contract with Intel:
On September 24, 2014, EP Global Communications, Inc. (EPGL) and Intel Corporation (Intel) executed an Initial Agreement. Additional Agreements are now pending. EPGL management believes that a relationship with Intel will be advantageous to shareholders as the two companies have synergistic goals in various fields. Details of further Agreements will be available upon mutual decision of the parties to disclose them publicly.

On September 24, 2014, EP Global Communications, Inc. (EPGL) and Intel Corporation (Intel) executed an initial Agreement. Additional Agreements are now pending.
https://www.otciq.com/otciq/ajax/showFinancialReportById.pdf?id=127990
 


Contract with AT&T: 
A new Development Agreement has been executed between AT&T and EPGL on January 4, 2015. As a result of this agreeement Joint Intellectual Properties are now being developed certain data streaming projects in mind. EPGL continues to create new and innovative technologies with large companies
New** EPGL and AT&T have created joint Intellectual Properties and are now in the process of procuring those properties (4/28/15)
https://www.otciq.com/otciq/ajax/showFinancialReportById.pdf?id=136848

EPGL and AT&T Developing Joint Intellectual Properties Companies Sign Development Agreement Resulting in New Inventions in IoT Data Streaming Space
https://www.otciq.com/otciq/ajax/showFinancialReportById.pdf?id=133983

EPGL and AT&T Sign Development Agreement
https://www.otciq.com/otciq/ajax/showFinancialReportById.pdf?id=132040



About EPGL Medical Science's Share Structure :

EPGL has a share structure of 5 billion authorized shares with approximately 4.5 billion shares restricted and a float of approximately 499 million. Following a very successful Reverse Split EPGL has decreased the float by 90% and increased share holder value by over 500% since that time. The company has strongly stated many times that they will not sell shares into the retail market. They are here to build a real company and implement real growth. Since restructuring EPGL has not increased the Float/OS/AS and have given us there word on countless occasions they will not do so. As of Start of January 2015 Pricewaterhouse Coopers and EPGL Reach Agreement to Reduce Outstanding and Authorized Shares.  Reduction of A/S and O/S is currently ongoing and first evidence of EPGL reducing shares will be shown in upcoming Quartley Report  Q3, 2015
LINKS TO SHARE RETIREMENT
** Press Release **  - Pricewaterhouse Coopers and EPGL Reach Agreement to Reduce Outstanding and Authorized Shares Beginning January 2015

** OTC Disclosure ** - Supplemental Information- Retirement of Common Shares by Beneficial Shareholders Commences

Pricewaterhouse Coopers, Corporate Finance and Recovery (Cayman) Ltd.Controlling Agent for:
AJW Qualified Partners, LLC, Controlled by PwC (PricewaterhouseCoopers) Worlds Largest Accounting Firm
1.975 Billion Common Shares
Mr. Michael Hayes
1.975 Billion Common Shares
FLOAT/TRADABLE SHARES : 499 Million ***Unchanged since Restructure in 2012***
Total number of shareholders of record 700 approximate 

ISSUERS FACILITIES
The Company leases or utilizes facilities in the following locations

Various California Bay Area Research Facilities Under NDA, David T. Markus, Ph.D.

Irvine, California – Research Facilities, Office

New York University Langone Medical Center, Corey W. Hunter M.D. / Eric Lee M.D.

University of Minnesota, David T. Markus, Ph.D.

University of California at Irvine, David T. Markus, Ph.D.

Dallas and Plano Texas, David T. Markus, Ph.D. **NEW**




Additional Information :
Letter From PricewaterhouseCoopers (Ian Stokoe) Congratulating EPGL on First  Devlopment Agreement (CooperVision)

Follow EPGL on Twitter @epglMED  https://twitter.com/EPGLMed
Follow EPGL on the WEB at http://www.epglmed.com





 

 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
EPGL
Current Price
Volume:
Bid Ask Day's Range
SureTrader
PostSubject
#110429  Sticky Note Agree shareholders have something great. franck92 10/08/16 01:34:47 PM
#108787  Sticky Note EPGL Wins Allowance on First Patent vikingzskillz 08/30/16 10:08:17 PM
#95482  Sticky Note Press releases or other company communication should not IH Brian (Retired) 01/12/16 12:14:18 PM
#112326   I haven't forgot... That's how I accumulated many gr8f1 12/10/16 07:00:52 AM
#112325   Wow folks...I almost forgot about this: Donguri 12/09/16 07:56:03 PM
#112321   Opinion duly noted. I believe the opposite in Doubledown22 12/09/16 06:32:53 PM
#112320   I find the speculation here over a possible skorz 12/09/16 06:11:22 PM
#112319   actually, I think there's a very good chance. Atlanta1 12/09/16 04:28:29 PM
#112318   Yeah, Franck, value is indeed growing. Patents H8ster 12/09/16 04:16:33 PM
#112317   "Buyout", Not a chance. AJCash 12/09/16 04:06:45 PM
#112316   Yup, looking good. Buyout from J&J will H8ster 12/09/16 04:03:29 PM
#112315   fairy tales from Mikey are certainly more entertaining Atlanta1 12/09/16 03:19:22 PM
#112312   Only your opinion. franck92 12/09/16 02:48:56 PM
#112310   Ok, so try to believe in Santa Claus, franck92 12/09/16 02:33:53 PM
#112309   No company, No one, even the big companies franck92 12/09/16 02:30:30 PM
#112308   Easier to believe in Santa Clause than EPGL/Mickey AJCash 12/09/16 02:30:09 PM
#112307   We believe we are now making headway Atlanta1 12/09/16 02:26:41 PM
#112306   But who said they have nothing ? franck92 12/09/16 02:22:55 PM
#112305   If JNJ buys at least the autofocus technology, franck92 12/09/16 02:20:10 PM
#112304   There are already well established facilities. AJCash 12/09/16 02:19:37 PM
#112302   "We will know more about this in January Stock Barber 12/09/16 02:14:42 PM
#112301   No it is much more easy to create franck92 12/09/16 02:14:26 PM
#112300   Hayes must think we are all mushrooms, fed Atlanta1 12/09/16 02:13:24 PM
#112299   We will know more about this in January 2017. franck92 12/09/16 02:11:23 PM
#112298   OLD EPGL release, plain junk AJCash 12/09/16 02:08:53 PM
#112297   So shareholders will have shares of franck92 12/09/16 02:07:42 PM
#112296   What is EPGL gaining from the New Company? AJCash 12/09/16 02:06:54 PM
#112294   LOL http://www.prnewswire.com/news-releases/johnson--johnson-vision-care-inc-se franck92 12/09/16 01:58:13 PM
#112293   $EPGL = Master of the Carrot Dangle Atlanta1 12/09/16 01:56:16 PM
#112292   Patents + agreement with JNJ for buying Epgl franck92 12/09/16 01:52:04 PM
#112291   Sure, EPGL is a company who owns all franck92 12/09/16 01:51:35 PM
#112290   38 DAYS UNTIL DISASTER STRIKES..!! Donguri 12/09/16 01:41:36 PM
#112289   The sky is falling....The sky is falling...haha. Valiant 12/09/16 01:30:47 PM
#112288   DISASTER FOR EPGL-SHAREHOLDERS ABOUT TO HAPPEN..!! Donguri 12/09/16 12:55:36 PM
#112287   If someone would kindly put up L2... epglholder 12/09/16 11:25:50 AM
#112286   I hope too. 22 "trading days" till the franck92 12/09/16 09:48:34 AM
#112285   It could be a high volume day today. judypudy 12/09/16 09:42:17 AM
#112284   It is simple, you said you have contacted franck92 12/09/16 01:31:11 AM
#112282   Go ahead and tell the SEC Koog 12/08/16 08:14:47 PM
#112281   Doubledown22, why are people that know about the flaflyersfan 12/08/16 06:37:44 PM
#112280   Why don't you ask the new private company Doubledown22 12/08/16 06:28:56 PM
#112279   Sounds good to me. I was thinking of judypudy 12/08/16 03:19:35 PM
#112277   What if an S-corp or LLC owns EPGL shares? wobblenuts 12/08/16 02:51:27 PM
#112276   New chapters are coming. EPGL has been H8ster 12/08/16 02:34:50 PM
#112275   "This new company hasn't even listed as a pinky" H8ster 12/08/16 02:23:34 PM
#112274   This is stupid! You're being offered coupons. This skorz 12/08/16 02:19:27 PM
#112273   "Surely they have thought of this? " LOL franck92 12/08/16 02:05:18 PM
#112272   Lol, nice!! $$$ EPGL $$$ vikingzskillz 12/08/16 02:01:25 PM
#112271   The equity gift will come from that separate, Stock Barber 12/08/16 02:01:02 PM
#112270   "I believe by January 16, 2017, it will franck92 12/08/16 01:44:02 PM
#112269   KOOG FYI From EPGL Investor Relations RFresDiver 12/08/16 01:30:00 PM
#112267   Good. Thanks to share if there is something special. franck92 12/08/16 12:17:15 PM
#112266   I just sent my request for gift shares. $EPGL dragonsfire 12/08/16 12:14:55 PM
PostSubject